Clinical Trials Logo

Folate Receptor Alpha Positive clinical trials

View clinical trials related to Folate Receptor Alpha Positive.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03106077 Completed - Clinical trials for Anatomic Stage III Breast Cancer AJCC v8

Mirvetuximab Soravtansine as First Line in Treating Patients With Triple Negative Breast Cancer

Start date: June 5, 2017
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well mirvetuximab soravtansine works as first line in treating patients with triple negative breast cancer. Drugs used in chemotherapy, such as mirvetuximab soravtansine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.